Previous Page  72 / 76 Next Page
Show Menu
Previous Page 72 / 76 Next Page
Page Background


Young Investigator Awards

| NCCN Annual Report 2016

Young Investigator Awards

True Innovation

The extensive growth of NCCN Foundation patient resources is

due, in part, to the exponential growth in oncology research and

breakthroughs. Each year, through its Young Investigator Awards

program, NCCN Foundation provides vital funding to some of

the nation’s top next-generation cancer researchers, guiding the

course of treatment innovation and advancement in cancer care.

In 2016, NCCN awarded seven grants—a total of

$1,050,000 million to the following investigators:

James Chen, MD, The Ohio State University

Comprehensive Cancer Center – James Cancer Hospital

and Solove Research Institute

Personalized Cancer Treatment Using a Patient-Centered

Similarity-Based Algorithm in Sarcoma

Geoffrey Sonn, MD, Stanford Cancer Institute

Application of Desorption Electrospray Mass

Spectrometry for Rapid Prostate Cancer Diagnosis and

Improved Risk Stratification

Ryan Nipp, MD, Dana-Farber/Brigham and Women’s

Cancer Center | Massachusetts General Hospital Cancer


Randomized Study of Perioperative Geriatric Evaluation

and Management of Older Patients with Gastrointestinal

Cancers Undergoing Surgical Resection

Elias Obeid, MD, MPH, Fox Chase Cancer Center

Systemic and Tumor Immunity Predictors of Response

to PD-1 Blockade with Carboplatin in Metastatic Triple-

Negative Breast Cancer

Saul Priceman, PhD, City of Hope Comprehensive Cancer


Immunotherapy for Prostate Cancer Combining CAR-

Engineered T Cells with Targeted Checkpoint Inhibition

Kathryn Ruddy, MD, Mayo Clinic Cancer Center

NCCN Guideline Adherence in Breast Cancer Survivors

Daniel Sherbenou, MD, PhD, University of Colorado Cancer


A Patient-Derived Xenograft Model of Multiple Myeloma

to Test Anti-CD46 Antibody Drug Conjugate for Curative


“My experience as a YIA grantee has exposed me to speaking

and presentation opportunities among the nation’s most

respected oncologists and allowed me to collaborate with

my esteemed group of YIA peers,” said Crystal Denlinger,

MD, FACP, Chief, GI Medical Oncology, Associate Professor,

Department of Hematology/Oncology, Fox Chase Cancer

Center, 2012 NCCN Foundation Young Investigator Awardee.


More information about Dr. Denlinger’s study is available at